Table 1 Polyamine pKas and ethidium bromide exclusion data
then cleaved by increasing the pH to 11 with conc. aq. ammonia, stirring
(25 °C, 15 h) to afford, after flash chromatography over silica gel (CH2Cl2–
MeOH–conc. aq. NH4OH 200:10:1 to 150:10:1 v/v/v), tetra-Boc
protected polyamine 5 (19%). Reaction of the free primary amine of 5 with
3-cholesteryl chloroformate (1.2 equiv., 3.0 equiv. TEA, CH2Cl2, 0 °C for
10 min then to 25 °C for 12 h) afforded, after purification over silica gel
(EtOAc–hexane 8:2 to 6:4 v/v) fully protected carbamate 10 (81%).
Deprotection (CH2Cl2–TFA 10:90 v/v, 0 °C, 2 h) and purification by RP-
HPLC over ABZ + Plus (5 mm, Supelcosil) (MeCN–0.1% aq. TFA 1:1 v/v,
l = 220 nm) afforded the polytrifluoroacetate salt of polyamine carbamate
10 (50%) HR-FABMS (+ve ion in m-NBA) [Found 602.5380 (M + 1).
Polyamine Measured pKas Net chargea Charge ratiob Conc./mmc
1
10.9 ± 0.01
10.1 ± 0.01
8.9 ± 0.01
8.1 ± 0.01
10.1 ± 0.06
8.6 ± 0.06
7.3 ± 0.05
10.7 ± 0.04
8.8 ± 0.02
7.2 ± 0.02
10.0 ± 0.02
8.0 ± 0.02
5.5 ± 0.02
9.3 ± 0.01
7.6 ± 0.01
5.7 ± 0.01
9.9 ± 0.20
8.4 ± 0.20
6.3 ± 0.21
3.9 ± 0.21
10.2 ± 0.10
8.6 ± 0.08
7.2 ± 0.09
4.4 ± 0.09
2.5 ± 0.28
3.8
> 4.0
> 17.0
6
2.4
2.3
1.8
1.6
2.0
0.62
0.76
0.80
0.88
0.92
1.3
1.6
1.7
2.4
2.7
7
C36H68N5O2 requires 602.5380].
§ Using the literature average weight per nucleotide of 330 Da.4
8
1 For selected reviews on polyamines, see B. Ganem, Acc. Chem. Res.,
1982, 15, 290; R. J. Bergeron, Acc. Chem. Res., 1986, 19, 105;
I. S. Blagbrough, S. Carrington and A. J. Geall, Pharm. Sci., 1997, 3,
223 and refs. cited therein.
2 J.-P. Behr, Tetrahedron Lett., 1986, 27, 5861; J.-P. Behr, Acc. Chem.
Res., 1993, 26, 274; N. Schmid and J.-P. Behr, Tetrahedron Lett., 1995,
36, 1447 and refs. cited therein.
3 S. C. Tam and R. J. P. Williams, Struct. Bonding, 1985, 63, 103;
E. Rowatt and R. J. P. Williams, J. Inorg. Biochem., 1992, 46, 87;
K. D. Stewart and T. A. Gray, J. Phys. Org. Chem., 1992, 5, 461;
V. A. Bloomfield, Curr. Opin. Struct. Biol., 1996, 6, 334.
4 P. L. Felgner, Y. Barenholz, J. P. Behr, S. H. Cheng, P. Cullis, L. Huang,
J. A. Jessee, L. Seymour, F. Szoka, A. R. Thierry, E. Wagner and G. Wu,
Hum. Gene Ther., 1997, 8, 511.
5 R. G. Crystal, Science, 1995, 270, 404; P. L. Felgner, Sci. Am., 1997,
276, 86; C. O’Driscoll, Chem. Brit., 1997, 33, 66; R. I. Mahato,
A. Rolland and E. Tomlinson, Pharm. Res., 1997, 14, 853; I. M. Verma
and N. Somia, Nature, 1997, 389, 239.
9
10
11
2.3
0.66
1.3
a Net positive charge calculated from the Henderson–Hasselbach equation
at pH 7.4. b Charge ratio4 at which 50% exclusion of ethidium bromide is
c
effected using calf thymus DNA at pH 7.4. Concentration of polyamine
6 E. R. Lee, J. Marshall, C. S. Siegel, C. Jiang, N. S. Yew, M. R. Nichols,
J. B. Nietupski, R. J. Ziegler, M. B. Lane, K. X. Wang, N. C. Wan,
R. K. Scheule, D. J. Harris, A. E. Smith and S. H. Cheng, Hum. Gene
Ther., 1996, 7, 1701; R. G. Cooper, C. J. Etheridge, L. Stewart,
J. Marshall, S. Rudginsky, S. H. Cheng and A. D. Miller, Chem. Eur. J.,
1988, 4, 137.
conjugate at which 50% exclusion of ethidium bromide (1.3 mm) is effected
using calf thymus DNA (3.0 mm) at pH 7.4.
centres and that it cannot be attributed to a single point. Even
when the first charge is introduced principally on the primary
amine, it is also distributed on to the secondary amines. This has
been shown using unsymmetrical triamine, spermidine.17
The four methylene central spacer found in spermine 1 has
also been shown to be important for binding affinity, confirming
that both the number of positive charges and their distribution
has a profound effect on the polyamine’s ability to induce DNA
conformational changes.18 The measured pKas for polyamines
containing aminopropyl16 and aminoethyl10 units and Trans-
fectam (DOGS)7,19 add further weight to this hypothesis. These
results will be of use in gene therapy studies and should find
ready application in the design of lipoplexes with particular
reference to spermidine and spermine class alkaloids. This
evaluation of pKa data, the number and regiochemical distribu-
tion of charges along the polyamine backbone, may lead to a
clearer understanding of lipoplex modes of action.
7 J.-P. Behr, B. Demeneix, J.-P. Loeffler and J. Perez-Mutul, Proc. Natl.
Acad. Sci. USA, 1989, 86, 6982.
8 I. S. Blagbrough, S. Taylor, M. L. Carpenter, V. Novoselskiy,
T. Shamma and I. S. Haworth, Chem. Commun., 1998, 929.
9 G. Byk, C. Dubertret, V. Escriou, M. Frederic, G. Jaslin, R. Rangara,
B. Pitard, J. Crouzet, P. Wils, B. Schwartz and D. Scherman, J. Med.
Chem., 1998, 41, 224.
10 J. K. Guy–Caffey, V. Bodepudi, J. S. Bishop, K. Jayaraman and
N. Chaudhary, J. Biol. Chem., 1995, 270, 31391; D. Moradpour,
J. I. Schauer, V. R. Zurawski, Jr., J. R. Wands and R. H. Boutin,
Biochem. Biophys. Res. Commun., 1996, 221, 82; S. Walker, M. J. Sofia,
R. Kakarla, N. A. Kogan, L. Wierichs, C. B. Longley, K. Bruker,
H. R. Axelrod, S. Midha, S. Babu and D. Kahne, Proc. Natl. Acad. Sci.
USA, 1996, 93, 1585.
11 H.-P. Hsieh, J. G. Muller and C. J. Burrows, J. Am. Chem. Soc., 1994,
116, 12077.
12 A. J. Geall and I. S. Blagbrough, Tetrahedron Lett., 1998, 39, 443.
13 I. S. Blagbrough and A. J. Geall, Tetrahedron Lett., 1998, 39, 439.
14 G. Anderegg and P. Bla¨uenstein, Helv. Chim. Acta, 1982, 65, 162.
15 R. J. Bergeron, J. S. McManis, W. R. Weimar, K. M. Schreier, F. Gao,
Q. Wu, J. Ortiz-Ocasio, G. R. Luchetta, C. Porter and J. R. T. Vinson,
J. Med. Chem., 1995, 38, 2278.
16 Y. Takeda, K. Samejima, K. Nagano, M. Watanabe, H. Sugeta and
Y. Kyogoku, Eur. J. Biochem., 1983, 130, 383; D. Aikens, S. Bunce,
F. Onasch, R. Parker, III, C. Hurwitz and S. Clemans, Biophys. Chem.,
1993, 17, 67.
17 M. M. Kimberly and J. H. Goldstein, Anal. Chem., 1981, 53, 789; D. A.
Aikens, S. C. Bunce, O. F. Onasch, H. M. Schwartz and C. Hurwitz,
J. Chem. Soc., Chem. Commun., 1983, 42.
18 H. S. Basu, H. C. A. Schwietert, B. G. Feuerstein and L. J. Marton,
Biochem. J., 1990, 269, 329.
We thank the EPSRC and Celltech Therapeutics Ltd, for a
CASE studentship (to A. J. G.). We acknowledge some
preliminary experimental work of Ms Dima Al-Hadithi (Uni-
versity of Bath) and useful discussions with Dr Ian S. Haworth
(University of Southern California). I. S. B. and I. S. H. are
recipients of a NATO grant (CRG 970290).
Notes and References
† E-mail: prsisb@bath.ac.uk
‡ An important first step is the ready purification of technical grade ( ~ 80%)
2.2.2.2-pentamine 2 by selective protection of one primary amino functional
group by reaction with ethyl trifluoroacetate (1.0 equiv., MeOH, 278 °C for
1 h then to 0 °C over 1 h) to form trifluoroacetamide 3. Immediately, in this
solution, the remaining four amino functional groups were Boc protected
with di-tert-butyl dicarbonate (5 equiv., 0–25 °C over 1 h then 14 h) to
afford fully protected polyamine 4. The trifluoroacetyl protecting group was
19 J.-S. Remy, C. Sirlin, P. Vierling and J.-P. Behr, Bioconjugate Chem.,
1994, 5, 647.
Received in Glasgow, UK, 30th April 1998; 8/03284J
1404
Chem. Commun., 1998